Literature DB >> 11283870

Drug-induced liver injury: mechanisms and test systems.

D M Bissell1, G J Gores, D L Laskin, J H Hoofnagle.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11283870     DOI： 10.1053/jhep.2001.23505

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  53 in total

1.  Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse.

Authors:  Franco Capra; Nicoletta Nicolini; Giovanni Morana; Alfredo Guglielmi; Paola Capelli; Italo Vantini
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 2.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

3.  Metabolism, pharmacokinetics, and hepatic disposition of xanthones and saponins on Zhimu treatments for exploratively interpreting the discrepancy between the herbal safety and timosaponin A3-induced hepatotoxicity.

Authors:  Yang Xie; Xu Zhou; Hu Pei; Ming-Cang Chen; Zhao-Lin Sun; Ya-Ru Xue; Xiao-Ting Tian; Cheng-Gang Huang
Journal:  Acta Pharmacol Sin       Date:  2018-05-23       Impact factor: 6.150

Review 4.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles.

Authors:  Timothy J Merkel; Stephen W Jones; Kevin P Herlihy; Farrell R Kersey; Adam R Shields; Mary Napier; J Christopher Luft; Huali Wu; William C Zamboni; Andrew Z Wang; James E Bear; Joseph M DeSimone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

6.  Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice.

Authors:  Adarsh Gandhi; Tao Guo; Pranav Shah; Bhagavatula Moorthy; Romi Ghose
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-11       Impact factor: 4.219

7.  Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice.

Authors:  Rômulo Dias Novaes; Eliziária C Santos; Marli C Cupertino; Daniel S S Bastos; Jerusa M Oliveira; Thaís V Carvalho; Mariana M Neves; Leandro L Oliveira; André Talvani
Journal:  Parasitol Res       Date:  2015-04-28       Impact factor: 2.289

8.  Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.

Authors:  Zhen Ren; Si Chen; Ji-Eun Seo; Xiaoqing Guo; Dongying Li; Baitang Ning; Lei Guo
Journal:  Toxicol In Vitro       Date:  2020-08-28       Impact factor: 3.500

9.  Hepatitis following famotidine: a case report.

Authors:  Nishant Gupta; Chirag Patel; Mukta Panda
Journal:  Cases J       Date:  2009-01-27

10.  Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).

Authors:  Yin Yin Xia; Dai Yu Hu; Fei Ying Liu; Xiao Meng Wang; Yan Li Yuan; De Hua Tu; Yi Xin Chen; Lin Zhou; Li Zhen Zhu; Wei Wei Gao; Hong Yuan Wang; Da Fang Chen; Li Yang; Ping Ping He; Xiao Ting Li; Ying Jian He; Feng Sun; Si Yan Zhan
Journal:  BMC Public Health       Date:  2010-05-21       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.